B. Vens-Cappell

发表

Bioequivalence of HX 575 ( recombinant human epoetin alfa ) and a comparator epoetin alfa after multiple intravenous administrations : an open-label randomised controlled trial

M. Kinzig, F. Sörgel, A. Vetter, 2015 .

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial

M. Kinzig, F. Sörgel, A. Vetter, 2009, BMC clinical pharmacology.

Bioequivalence of HX575 (Recombinant Human Epoetin Alfa) and a Comparator Epoetin Alfa after Multiple Subcutaneous Administrations

M. Kinzig, F. Sörgel, A. Vetter, 2008, Pharmacology.

Biosimilarity of HX575 (human recombinant epoetin alfa) and epoetin beta after multiple subcutaneous administration.

M. Kinzig, F. Sörgel, A. Vetter, 2009, International journal of clinical pharmacology and therapeutics.

The effects of extrusion and pelleting of feed for trout on the digestibility of protein, amino acids and energy and on feed conversion

B. Vens-Cappell, 1984 .

Methodical studies on digestion in trout. 1. Reliability of digestion coefficients in relation to methods for faeces collection

B. Vens-Cappell, 1985 .

Proof of Systemic Safety of a Lidocaine Ointment in the Treatment of Patients with Anorectal Pain

D. Mazur, D. Seiler, R. Schlegelmilch, 2007, Arzneimittelforschung.

Bioavailability and Pharmacokinetic Profile of Dihydroergotoxine from a Tablet and from an Oral Solution Formulation

L. Rovati, K. Schmid, K. Schmid, 2001, Arzneimittelforschung.

Study on the Interaction of the Dopamine Agonist α-Dihydroergocryptine with the Pharmacokinetics of Digoxin

C. D. De Mey, D. Mazur, M. Althaus, 2000, Arzneimittelforschung.

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial

M. Kinzig, F. Sörgel, A. Vetter, 2009, BMC clinical pharmacology.